Cargando…
Importation and Circulation of Vaccine-Derived Poliovirus Serotype 2, Senegal, 2020–2021
Environmental surveillance for poliovirus is increasingly used in poliovirus eradication efforts as a supplement to acute flaccid paralysis (AFP) surveillance. Environmental surveillance was officially established in 2017 in Senegal, where no poliovirus had been detected since 2010. We tested sewage...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514370/ https://www.ncbi.nlm.nih.gov/pubmed/36148906 http://dx.doi.org/10.3201/eid2810.220847 |
_version_ | 1784798260395769856 |
---|---|
author | Faye, Martin Kébé, Ousmane Diop, Boly Ndiaye, NDack Dosseh, Annick Sam, Abdoulaye Diallo, Aliou Dia, Hamet Diallo, Jean Pierre Dia, Ndongo Kiori, Davy Evrard Diop, Ousmane Madiagne Sall, Amadou Alpha Faye, Ousmane |
author_facet | Faye, Martin Kébé, Ousmane Diop, Boly Ndiaye, NDack Dosseh, Annick Sam, Abdoulaye Diallo, Aliou Dia, Hamet Diallo, Jean Pierre Dia, Ndongo Kiori, Davy Evrard Diop, Ousmane Madiagne Sall, Amadou Alpha Faye, Ousmane |
author_sort | Faye, Martin |
collection | PubMed |
description | Environmental surveillance for poliovirus is increasingly used in poliovirus eradication efforts as a supplement to acute flaccid paralysis (AFP) surveillance. Environmental surveillance was officially established in 2017 in Senegal, where no poliovirus had been detected since 2010. We tested sewage samples from 2 sites in Dakar monthly for polioviruses. We identified a vaccine-derived poliovirus serotype 2 on January 19, 2021, from a sample collected on December 24, 2020; by December 31, 2021, we had detected 70 vaccine-derived poliovirus serotype 2 isolates circulating in 7 of 14 regions in Senegal. Sources included 18 AFP cases, 20 direct contacts, 17 contacts in the community, and 15 sewage samples. Phylogenetic analysis revealed the circulation of 2 clusters and provided evidence on the virus introduction from Guinea. Because novel oral polio vaccine serotype 2 was used for response activities throughout Senegal, we recommend expanding environmental surveillance into other regions. |
format | Online Article Text |
id | pubmed-9514370 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-95143702022-10-01 Importation and Circulation of Vaccine-Derived Poliovirus Serotype 2, Senegal, 2020–2021 Faye, Martin Kébé, Ousmane Diop, Boly Ndiaye, NDack Dosseh, Annick Sam, Abdoulaye Diallo, Aliou Dia, Hamet Diallo, Jean Pierre Dia, Ndongo Kiori, Davy Evrard Diop, Ousmane Madiagne Sall, Amadou Alpha Faye, Ousmane Emerg Infect Dis Research Environmental surveillance for poliovirus is increasingly used in poliovirus eradication efforts as a supplement to acute flaccid paralysis (AFP) surveillance. Environmental surveillance was officially established in 2017 in Senegal, where no poliovirus had been detected since 2010. We tested sewage samples from 2 sites in Dakar monthly for polioviruses. We identified a vaccine-derived poliovirus serotype 2 on January 19, 2021, from a sample collected on December 24, 2020; by December 31, 2021, we had detected 70 vaccine-derived poliovirus serotype 2 isolates circulating in 7 of 14 regions in Senegal. Sources included 18 AFP cases, 20 direct contacts, 17 contacts in the community, and 15 sewage samples. Phylogenetic analysis revealed the circulation of 2 clusters and provided evidence on the virus introduction from Guinea. Because novel oral polio vaccine serotype 2 was used for response activities throughout Senegal, we recommend expanding environmental surveillance into other regions. Centers for Disease Control and Prevention 2022-10 /pmc/articles/PMC9514370/ /pubmed/36148906 http://dx.doi.org/10.3201/eid2810.220847 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Faye, Martin Kébé, Ousmane Diop, Boly Ndiaye, NDack Dosseh, Annick Sam, Abdoulaye Diallo, Aliou Dia, Hamet Diallo, Jean Pierre Dia, Ndongo Kiori, Davy Evrard Diop, Ousmane Madiagne Sall, Amadou Alpha Faye, Ousmane Importation and Circulation of Vaccine-Derived Poliovirus Serotype 2, Senegal, 2020–2021 |
title | Importation and Circulation of Vaccine-Derived Poliovirus Serotype 2, Senegal, 2020–2021 |
title_full | Importation and Circulation of Vaccine-Derived Poliovirus Serotype 2, Senegal, 2020–2021 |
title_fullStr | Importation and Circulation of Vaccine-Derived Poliovirus Serotype 2, Senegal, 2020–2021 |
title_full_unstemmed | Importation and Circulation of Vaccine-Derived Poliovirus Serotype 2, Senegal, 2020–2021 |
title_short | Importation and Circulation of Vaccine-Derived Poliovirus Serotype 2, Senegal, 2020–2021 |
title_sort | importation and circulation of vaccine-derived poliovirus serotype 2, senegal, 2020–2021 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514370/ https://www.ncbi.nlm.nih.gov/pubmed/36148906 http://dx.doi.org/10.3201/eid2810.220847 |
work_keys_str_mv | AT fayemartin importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021 AT kebeousmane importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021 AT diopboly importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021 AT ndiayendack importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021 AT dossehannick importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021 AT samabdoulaye importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021 AT dialloaliou importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021 AT diahamet importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021 AT diallojeanpierre importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021 AT diandongo importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021 AT kioridavyevrard importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021 AT diopousmanemadiagne importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021 AT sallamadoualpha importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021 AT fayeousmane importationandcirculationofvaccinederivedpoliovirusserotype2senegal20202021 |